Medtronic reported a decrease in revenue by 0.8% to $7.6 billion. The GAAP diluted EPS was $0.36, and the non-GAAP diluted EPS was $1.02.
Q2 Revenue of $7.6 Billion decreased 0.8% as reported and 1.5% organic.
Q2 GAAP Diluted EPS of $0.36
Q2 Non-GAAP Diluted EPS of $1.02
Second quarter U.S. revenue of $4.054 billion represented 53 percent of company revenue and decreased 2 percent as reported and organic.
Given the uncertainty on near-term financial results caused by the COVID-19 pandemic, the company is not providing formal annual or quarterly financial guidance at this time.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance